These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9209314

  • 1. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.
    Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka T, Miyasaka M, Ito M, Ueyama Y, Yamamoto N.
    Leukemia; 1997 Apr; 11 Suppl 3():109-12. PubMed ID: 9209314
    [Abstract] [Full Text] [Related]

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E, Aquaro S, Lapenta C, Amendola A, Spada M, Covaceuszach S, Perno CF, Belardelli F.
    Proc Natl Acad Sci U S A; 2003 Jul 22; 100(15):8927-32. PubMed ID: 12853577
    [Abstract] [Full Text] [Related]

  • 6. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A, Tanaka R, Kodama A, Yamamoto N, Ansari AA, Tanaka Y.
    Clin Dev Immunol; 2005 Dec 22; 12(4):235-42. PubMed ID: 16584108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL.
    J Immunol; 2000 Jul 01; 165(1):518-27. PubMed ID: 10861091
    [Abstract] [Full Text] [Related]

  • 10. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
    Koup RA, Hesselton RM, Safrit JT, Somasundaran M, Sullivan JL.
    AIDS Res Hum Retroviruses; 1994 Mar 01; 10(3):279-84. PubMed ID: 8018388
    [Abstract] [Full Text] [Related]

  • 11. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
    Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB, Rajan TV, Gott B, Roopenian DC, Shultz LD.
    J Immunol; 1997 Apr 15; 158(8):3578-86. PubMed ID: 9103418
    [Abstract] [Full Text] [Related]

  • 12. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha.
    Lapenta C, Santini SM, Logozzi M, Spada M, Andreotti M, Di Pucchio T, Parlato S, Belardelli F.
    J Exp Med; 2003 Jul 21; 198(2):361-7. PubMed ID: 12874266
    [Abstract] [Full Text] [Related]

  • 13. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
    Berney T, Molano RD, Pileggi A, Cattan P, Li H, Ricordi C, Inverardi L.
    Transplantation; 2001 Jul 15; 72(1):133-40. PubMed ID: 11468548
    [Abstract] [Full Text] [Related]

  • 14. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX, Cheng Q, Chen HZ, Xie X, Ye DF.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1465-9. PubMed ID: 15500747
    [Abstract] [Full Text] [Related]

  • 15. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
    Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H, Mizusawa H, Koyanagi Y.
    J Exp Med; 2001 Mar 05; 193(5):651-60. PubMed ID: 11238596
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
    Reinhardt B, Torbett BE, Gulizia RJ, Reinhardt PP, Spector SA, Mosier DE.
    AIDS Res Hum Retroviruses; 1994 Feb 05; 10(2):131-41. PubMed ID: 8198867
    [Abstract] [Full Text] [Related]

  • 18. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R, Torbett BE, Gulizia RJ, Leath S, Mosier DE, Koenig S.
    J Immunol; 1994 Nov 15; 153(10):4826-33. PubMed ID: 7963548
    [Abstract] [Full Text] [Related]

  • 19. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL.
    J Immunol; 1995 Jan 01; 154(1):180-91. PubMed ID: 7995938
    [Abstract] [Full Text] [Related]

  • 20. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M, Brown SA, Tutt LM, Tan J, Seehafer DL, Harris JP, Xun CQ, Thompson JS.
    Clin Transplant; 1997 Oct 01; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.